Trevena, Inc. TRVN
Regular-session close
- YTD
- -95.83%
- 1 year
- -95.83%
Discussion (68)
Shut your trap @derek , with all this bullshit
Trevena, Inc. (TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Carrie Bourdow, President and Chief Executive Officer, will participate in a fireside chat at the JMP Securities CNS Forum, being held virtually on August 19 – 20, 2020.
TRVN Uptrend daily charts
Look I am a rookie trader and even I know how important this drug is.
You will regret selling this one day
$TRVN will be fine. Hold strong and be patient.
I’m holding strong but damn this is testing my rookie ass. Trying to be intelligent about it and be strong.
Earnings after market?
More volume but it’s not going up whyyy??
I think it will fill the gap firts at around 7ish. Then we will see All Time High. This is my wish of course.
